Literatur zum Kapitel Demenz (teilweise nur direkt im Kapitel als Link
ausgewiesen). Je nach Zeitschrift sind nicht alle Artikel im Volltext frei
abrufbar. Zeitschriften wie das BMJ haben alle Artikel frei, manche
Zeitschriften erwarten eine Registrierung und haben auch dann nur ältere Artikel
frei verfügbar. Für Abonnenten sind nach Registrierung bei allen Zeitschriften
die Artikel frei verfügbar.
-
Mahyar Etminan, Sudeep Gill, and Ali Samii,
Effect of non-steroidal anti-inflammatory
drugs on risk of Alzheimer's disease: systematic review and meta-analysis of
observational studies
BMJ 2003; 327: 128.[Abstract]
[Abridged text]
[Abridged PDF]
[Full text]
[PDF]
-
A. D. Smith
Imaging the
progression of Alzheimer pathology through the brain PNAS,
April 2, 2002; 99(7): 4135 - 4137.
[Full Text]
[PDF]
- A.
P. Porsteinsson, P. N. Tariot, R. Erb, C. Cox, E. Smith, L. Jakimovich, J.
Noviasky, N. Kowalski, C. J. Holt, and C. Irvine Placebo-Controlled Study of
Divalproex Sodium for Agitation in Dementia Am. J. Geriatr. Psychiatry,
February 1, 2001; 9(1): 58 - 66.
[Abstract]
[Full Text]
-
A. Stevens,
R. Milne, R. Lilford, and J. Gabbay
Keeping pace with new
technologies: systems needed to identify and evaluate them
BMJ, November 13, 1999; 319(7220): 1291 - 1291.
[Full Text]
-
Abdel-sayed
WS, Toppozada HK, Said SA, El-sayed OK. Some metabolic and hormonal changes
in women using long acting injectable contraceptives. Alex J Pharm Sci.
1989;3:29-32.
MEDLINE
-
Abraham, W.
C., Logan, B., Greenwood, J. M., Dragunow, M. (2002). Induction and
Experience-Dependent Consolidation of Stable Long-Term Potentiation Lasting
Months in the Hippocampus. J. Neurosci. 22: 9626-9634
[Abstract]
[Full Text]
-
Ahmed, S.,
Mozley, P. D., Potter, W. Z. (2002). Biomarkers in Psychotropic Drug
Development. AJGP 10: 678-686
[Abstract]
[Full Text]
-
Aisen, P. S.,
Egelko, S., Andrews, H., Diaz-Arrastia, R., Weiner, M., DeCarli, C., Jagust,
W., Miller, J. W., Green, R., Bell, K., Sano, M. (2003). A Pilot Study of
Vitamins to Lower Plasma Homocysteine Levels in Alzheimer Disease. AJGP 11:
246-249
[Abstract]
[Full Text]
-
Andrieu et
al. Association of Alzheimer's Disease Onset With Ginkgo Biloba and Other
Symptomatic Cognitive Treatments in a Population of Women Aged 75 Years and
Older From the EPIDOS Study J Gerontol A Biol Sci Med Sci 2003;58:M372-377.
ABSTRACT
|
FULL TEXT
-
Ang-Lee et
al. Herbal Medicines and Perioperative Care JAMA 2001;286:208-216.
ABSTRACT
|
FULL TEXT
-
Astin
Complementary and Alternative Medicine and the Need for Evidence-based
Criticism Acad Med 2002;77:864-868.
FULL TEXT
-
B. LAWLOR
Managing behavioural and psychological symptoms in dementia Br. J.
Psychiatry, December 1, 2002; 181(6): 463 - 465.
[Full Text]
[PDF]
-
B. Pitt
Coping with
loss: Loss in late life BMJ, May 9, 1998; 316(7142): 1452 -
1454.
[Full Text]
-
Bartels et
al. Evidence-Based Practices in Geriatric Mental Health Care PS
2002;53:1419-1431.
ABSTRACT |
FULL TEXT
-
Bartels, S. J., Dums, A. R., Oxman, T. E., Schneider, L. S., Arean, P. A.,
Alexopoulos, G. S., Jeste, D. V. (2002).
Evidence-Based Practices in Geriatric Mental Health Care. PS 53: 1419-1431
[Abstract]
[Full Text]
-
Bernabei
Review: Ginkgo biloba extract improves cognitive function in mild to
moderate Alzheimer's disease Evid Based Ment Health 1999;2:82-82.
FULL TEXT
-
Biegon, A.,
Alvarado, M., Budinger, T. F., Grossman, R., Hensley, K., West, M. S.,
Kotake, Y., Ono, M., Floyd, R. A. (2002). Region-selective effects of
neuroinflammation and antioxidant treatment on peripheral benzodiazepine
receptors and NMDA receptors in the rat brain.
J Neurochem 82: 924-934
[Abstract]
[Full Text]
-
Birkenhäger WH, Forette F, Seux ML, Wang JG, Staessen JA.
Blood
pressure, cognitive functions, and prevention of dementias in older patients
with hypertension.Arch Intern Med.2001;161:152-156.
ABSTRACT
MEDLINE
Breteler MMB. Vascular risk factors for Alzheimer's disease: an
epidemiologic perspective.Neurobiol Aging.2000;21:153-160.MEDLINE
-
Borroni, B., Agosti, C., Panzali, A.F., Di Luca, M., Padovani, A., Miller,
J.W., Green, R., Mungas, D.M., Reed, B.R., Jagust, W.J. (2002).
Homocysteine,
vitamin B6, and vascular disease in patients with AD. Neurology 59:
1475-1476
[Full Text]
-
Boutaud, O., Ou,
J. J., Chaurand, P., Caprioli, R. M., Montine, T. J., Oates, J. A. (2002).
Prostaglandin H2 (PGH2 ) accelerates formation of amyloid {beta}1-42
oligomers. J Neurochem 82: 1003-1006
[Abstract]
[Full Text]
-
Bowen RL,
Isley JP, Atkinson RL. An association of elevated serum gonadotropin
concentrations and Alzheimer disease? J Neuroendocrinol. 2000;12:351-354.
MEDLINE
-
Bowen RL,
Smith MA, Harris PL, et al. Elevated luteinizing hormone expression
colocalizes with neurons vulnerable to Alzheimer's disease pathology. J
Neurosci Res. 2002;70:514-518.
MEDLINE
-
Braak, H. &
Braak, E. (1991)
Acta Neuropathologica 82, 239-259
-
Breitner, J. C.S., Zandi, P. P. (2001).
Do
Nonsteroidal Antiinflammatory Drugs Reduce the Risk of Alzheimer's Disease?.
N Engl J Med 345: 1567-1568
[Full Text]
-
Brenner DE,
Kukull WA, Stergachis A, et al. Postmenopausal estrogen therapy and the risk
of Alzheimer's disease: a population-based case-control study. Am J
Epidemiol. 1994;140:262-267.
MEDLINE
-
Buccafusco
and Terry Multiple Central Nervous System Targets for Eliciting Beneficial
Effects on Memory and Cognition J. Pharmacol. Exp. Ther. 2000;295:438-446.
ABSTRACT
|
FULL TEXT
-
Burggren, A.
C., Small, G. W., Sabb, F. W., Bookheimer, S. Y. (2002). Specificity of
Brain Activation Patterns in People at Genetic Risk for Alzheimer Disease.
AJGP 10: 44-51
[Abstract]
[Full Text]
-
Buttini, M., Yu, G.-Q., Shockley, K., Huang, Y., Jones, B., Masliah, E.,
Mallory, M., Yeo, T., Longo, F. M., Mucke, L. (2002).
Modulation of
Alzheimer-Like Synaptic and Cholinergic Deficits in Transgenic Mice by Human
Apolipoprotein E Depends on Isoform , Aging, and Overexpression of Amyloid
beta Peptides But Not on Plaque Formation. J. Neurosci. 22: 10539-10548
[Abstract]
[Full Text]
-
C, Samsioe
G, Lidfelt J, Nerbrand C, Agardh CD. Important factors for use of hormone
replacement therapy: a population-based study of Swedish women. Menopause.
2000;7:273-281.
MEDLINE
-
C. G.
Lyketsos, O. Lopez, B. Jones, A. L. Fitzpatrick, J. Breitner, and S. DeKosky
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive
Impairment: Results From the Cardiovascular Health Study JAMA,
September 25, 2002; 288(12): 1475 - 1483.
[Abstract]
[Full Text]
[PDF]
-
Calabrese
Psycho 28/2002
-
Chang, L., Speck, O., Miller, E. N., Braun, J., Jovicich, J., Koch, C., Itti,
L., Ernst, T. (2001).
Neural
correlates of attention and working memory deficits in HIV patients.
Neurology 57: 1001-1007
[Abstract]
[Full Text]
-
Christen
Oxidative stress and Alzheimer disease1 Am. J. Clin. Nutr. 2000;71:621s-629.ABSTRACT
|
FULL TEXT
-
D. Melzer
Personal
paper: New drug treatment for Alzheimer's disease: lessons for healthcare
policy BMJ, March 7, 1998; 316(7133): 762 - 764.
[Full Text]
-
Day, M.,
Morris, R. G. M., Shimizu, E., Tang, Y.-P., Rampon, C., Feng, R., Shrom, D.,
Tsien, J. Z. (2001). Memory Consolidation and NMDA Receptors: Discrepancy
Between Genetic and Pharmacological Approaches. Science 293: 755a-755
[Full Text]
-
De Bree, A.,
Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., Blom, H. J.
(2002).
Homocysteine
Determinants and the Evidence to What Extent Homocysteine Determines the
Risk of Coronary Heart Disease. Pharmacological Reviews 54: 599-618
[Abstract]
[Full Text]
- De
Deyn PP, Rabheru K, Rasmussen A, Bocksberger JP, Dautzenberg PL, Eriksson S,
Lawlor BA, Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M.
Comparison of risperidone and placebo for psychosis and behavioral
disturbances associated with dementia: a randomized, double-blind trial.
Risperidone Study Group. J Clin Psychiatry. 1999 Feb;60(2):107-15
-
DE LA TORRE, J.
C. (2002).
Vascular
Basis of Alzheimer's Pathogenesis. Annals NYAS Online 977: 196-215
[Abstract]
[Full Text]
- den
Heijer, T., Vermeer, S. E, Clarke, R., Oudkerk, M., Koudstaal, P. J., Hofman,
A., Breteler, M. M. B. (2002). Homocysteine and brain atrophy on MRI of
non-demented elderly.
Brain 126:
170-175
[Abstract]
[Full Text]
-
Di Ciano, P.,
Cardinal, R. N., Cowell, R. A., Little, S. J., Everitt, B. J. (2001).
Differential Involvement of NMDA, AMPA/Kainate, and Dopamine Receptors in
the Nucleus Accumbens Core in the Acquisition and Performance of Pavlovian
Approach Behavior.
J. Neurosci. 21:
9471-9477
[Abstract]
[Full Text]
-
Dik, M. G.,
Jonker, C., Comijs, H. C., Bouter, L. M., Twisk, J. W.R., van Kamp, G. J.,
Deeg, D. J.H. (2001).
Memory
complaints and APOE-{epsilon}4 accelerate cognitive decline in cognitively
normal elderly. Neurology 57: 2217-2222
[Abstract]
[Full Text]
-
Elevated
Homocysteine Is a Risk Factor for Alzheimer's Disease. Journal Watch
Neurology 2002: 4-4
[Full Text]
-
Eric M.
Reiman, Richard J. Caselli, Kewei Chen, Gene E. Alexander, Daniel Bandy, and
Jennifer Frost
Declining brain activity in cognitively normal apolipoprotein E
4
heterozygotes: A foundation for using positron emission tomography to
efficiently test treatments to prevent Alzheimer's disease
PNAS 2001 98:
3334-3339.
[Abstract]
[Full Text]
[PDF]
-
Ernst and
Cohen Informed Consent in Complementary and Alternative Medicine Arch Intern
Med 2001;161:2288-2292.
FULL TEXT
-
Ernst, T.,
Chang, L., Jovicich, J., Ames, N., Arnold, S. (2002). Abnormal brain
activation on functional MRI in cognitively asymptomatic HIV patients.
Neurology 59:
1343-1349
[Abstract]
[Full Text]
-
Evers, M. R., Salmen, B., Bukalo, O., Rollenhagen, A., Bosl, M. R.,
Morellini, F., Bartsch, U., Dityatev, A., Schachner, M. (2002).
Impairment of
L-type Ca2+ Channel-Dependent Forms of Hippocampal Synaptic Plasticity in
Mice Deficient in the Extracellular Matrix Glycoprotein Tenascin-C. J.
Neurosci. 22: 7177-7194
[Abstract]
[Full Text]
-
Fabiszewski
KJ, Volicer B, Volicer L. Effect of antibiotic treatment on outcome of
fevers in institutionalized Alzheimer patients. JAMA. 1990;263:3168-3172.
MEDLINE
-
Fazel, S.
(2002). Increased plasma total homocysteine levels increased the risk for
dementia in the elderly.
Evid Based Med 7: 160-160
[Full Text]
-
Foley, D. J.,
Masaki, K., White, L., Redline, S., Mignot, E., Murphy, Jr, G. M., Young, T.
(2001). Relationship Between Apolipoprotein E {epsilon}4 and
Sleep-Disordered Breathing at Different Ages.
JAMA 286: 1447-1448
[Full Text]
-
Françoise
Forette et al, The Prevention of Dementia With Antihypertensive Treatment,
New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study Arch
Intern Med. 2002;162:2046-2052
-
Fratiglioni
L, Ahlbom A, Viitanen M, Winblad B.Risk factors for late-onset Alzheimer's
disease: a population-based, case-control study.Ann Neurol.1993;33:258-266.MEDLINE
-
Fratiglioni L, De Ronchi D, Agüero-Torres H. Worldwide prevalence and
incidence of dementia. Drugs Aging.1999;15:365-375.
MEDLINE
-
Frenchman IB,
Prince T. Clinical experience with risperidone, haliperidal and thioridazine
for dementia-associated behavioural distubances. Int Psychogeriatr 9(4):
431-5 (Dec. 1997)
-
FRISONI, G B
(2001). Structural imaging in the clinical diagnosis of Alzheimer's disease:
problems and tools.
J. Neurol. Neurosurg.
Psychiatry 70: 711-718
[Full Text]
-
Fugh-Berman
and Cott Dietary Supplements and Natural Products as Psychotherapeutic
Agents Psychosom Med 1999;61:712-728.
ABSTRACT
|
FULL TEXT
-
G. T.
Grossberg and A. K. Desai Management of Alzheimer's Disease J. Gerontol. A
Biol. Sci. Med. Sci., April 1, 2003; 58(4): M331 - 353.
[Full Text]
[PDF]
-
Garibotto, G.,
Sofia, A., Saffioti, S., Russo, R., Deferrari, G., Rossi, D., Verzola, D.,
Gandolfo, M. T., Sala, M. R. (2003).
Interorgan
exchange of aminothiols in humans. Am. J. Physiol. 284: E757-763
[Abstract]
[Full Text]
- Gary
W. Small, Linda M. Ercoli, Daniel H. S. Silverman, S.-C. Huang, Scott Komo,
Susan Y. Bookheimer, Helen Lavretsky, Karen Miller, Prabha Siddarth, Natalie
L. Rasgon, John C. Mazziotta, Sanjaya Saxena, H. M. Wu, Michael S. Mega,
Jeffrey L. Cummings, Ann M. Saunders, Margaret A. Pericak-Vance, Allen D.
Roses, Jorge R. Barrio, and Michael E. Phelps
From the Cover: Cerebral metabolic and cognitive decline in persons at
genetic risk for Alzheimer's disease
PNAS 2000 97: 6037-6042; published online before print as
10.1073/pnas.090106797
[Abstract]
[Full Text]
[PDF]
-
Gayatri Devi,
MD; Ruth Ottman, PhD; Ming-Xin Tang, PhD; Karen Marder, MD, MPH; Yaakov
Stern, PhD; Richard Mayeux, MD, MSc Familial Aggregation of Alzheimer
Disease Among Whites, African Americans, and Caribbean Hispanics in Northern
Manhattan January 2000ABSTRACT
|
FULL TEXT
|
PDF
-
Geerlings MI,
Ruitenberg A, Witteman JCM, et al.
Reproductive
period and risk of dementia in postmenopausal women.
JAMA.
2001;285:1475-1481.ABSTRACT
| FULL
TEXT | PDF
-
George S.
Alexopoulos, M.D. Jonathan M. Silver, M.D. David A. Kahn, M.D. Allen
Frances, M.D. Daniel Carpenter, Ph.D The Expert Consensus Guideline Series,
Treatment of Agitation in Older Persons with Dementia Editors for the
Guidelines, .
www.psychguides.com/index.html
-
Goodman, A. B.,
Pardee, A. B. (2003).
Evidence for
defective retinoid transport and function in late onset Alzheimer's disease.
Proc. Natl. Acad. Sci. U. S. A. 100: 2901-2905
[Abstract]
[Full Text]
-
Gossen, M.,
Bujard, H. (2002). STUDYING GENE FUNCTION IN EUKARYOTES BY CONDITIONAL GENE
INACTIVATION. Annu. Rev. Genet. 36: 153-173
[Abstract]
[Full Text]
-
Grady D,
Herrington D, Bittner V, et al, for the HERS Research Group. Cardiovascular
disease outcomes during 6.8 years of hormone therapy: Heart and
Estrogen/progestin Replacement Study follow-up (HERS II).
JAMA. 2002;288:49-57.
ABSTRACT | FULL
TEXT | PDF
| MEDLINE
-
Grady D, Rubin
SM, Petitti DB, et al.
Hormone
therapy to prevent disease and prolong life in postmenopausal women.
Ann Intern Med.
1992;117:1016-1036.
MEDLINE
-
Greenberg, S.
M. (2002). Cerebral amyloid angiopathy and dementia: Two amyloids are worse
than one. Neurology
58: 1587-1588
[Full Text]
-
Greicius, M D, Geschwind, M D, Miller, B L (2002).
Presenile
dementia syndromes: an update on taxonomy and diagnosis.
J. Neurol. Neurosurg.
Psychiatry 72: 691-700
[Abstract]
[Full Text]
-
Greicius, M D, Geschwind, M D, Miller, B L (2002).
Presenile
dementia syndromes: an update on taxonomy and diagnosis.
J. Neurol. Neurosurg.
Psychiatry 72: 691-700
[Abstract]
[Full Text]
-
Grossberg and
Desai Management of Alzheimer's Disease J Gerontol A Biol Sci Med Sci
2003;58:M331-353.
FULL TEXT
-
Hachinski
V.Vascular dementia: the need for a new approach. J Intern
Med.1997;242:277-279.MEDLINE
- Han,
Q., Xu, M., Tang, L., Tan, X., Tan, X., Tan, Y., Hoffman, R. M. (2002).
Homogeneous, Nonradioactive, Enzymatic Assay for Plasma Pyridoxal
5-Phosphate. Clin Chem 48: 1560-1564
[Abstract]
[Full Text]
-
Hariri, A. R, Weinberger, D. R (2003).
Imaging
genomics. Br Med Bull 65: 259-270
[Abstract]
[Full Text]
-
Helene
Benveniste, Gillian Einstein, Katie R. Kim, Christine Hulette, and G. Allan
Johnson Detection of neuritic plaques in Alzheimer's disease by magnetic
resonance microscopy
PNAS 1999 96: 14079-14084.
[Abstract]
[Full Text]
[PDF]
-
Henderson VW,
Paganini-Hill A, Miller BL, et al. Estrogen for Alzheimer's disease in
women: randomized, double-blind, placebo-controlled trial.
Neurology.
2000;54:295-301.
MEDLINE
- Hock C, Konietzko U,
Streffer JR, Tracy J, Signorell A, Muller-Tillmanns B, Lemke U, Henke K,
Moritz E, Garcia E, Wollmer MA, Umbricht D, de Quervain DJ, Hofmann M,
Maddalena A, Papassotiropoulos A, Nitsch RM., Antibodies against
beta-Amyloid Slow Cognitive Decline in Alzheimer's Disease.
Neuron. 2003 May 22;38(4):547-54
-
Homocysteine
-- Risk Factor for Alzheimer's Disease?. Journal Watch Psychiatry 2002:
10-10
[Full Text]
-
Homocysteine
-- Risk Factor for Alzheimer's Disease?. Journal Watch (General) 2002: 1-1
[Full Text]
-
Hulley S,
Grady D, Bush T, et al, for the Heart and Estrogen/progesterone Replacement
Study (HERS) Research Group. Randomized trial of estrogen plus progestin for
secondary prevention of coronary heart disease in postmenopausal women.
JAMA.
1998;280:605-613.
ABSTRACT | FULL
TEXT | PDF
| MEDLINE
-
Husaini, B.
A., Moonis, M., Levine, R. (2003). Dementia and Hormone Use. PS 54: 575-575
[Full Text]
-
Iadecola, C.,
Gorelick, P. B. (2003).
Converging
Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia.
Stroke 34: 335-337
[Full Text]
-
J. F. Reilly,
D. Games, R. E. Rydel, S. Freedman, D. Schenk, W. G. Young, J. H. Morrison,
and F. E. Bloom Amyloid deposition in the hippocampus and entorhinal cortex:
Quantitative analysis of a transgenic mouse model PNAS, April 15, 2003;
100(8): 4837 - 4842.
[Abstract]
[Full Text]
[PDF]
-
Jack, C. R. ,
Petersen, R. C. , Xu, Y. , O'Brien, P. C. , Smith, G. E. , Ivnik, R. J. ,
Boeve, B. F. , Tangalos, E. G. & Kokmen, E. Rates of hippocampal atrophy
correlate with change in clinical status in aging and AD (2000)
Neurology 55, 484-489
-
Jakubowski,
H. (2002). Homocysteine Is a Protein Amino Acid in Humans. IMPLICATIONS FOR
HOMOCYSTEINE-LINKED DISEASE. J. Biol. Chem. 277: 30425-30428
[Abstract]
[Full Text]
-
K. Scott, R.
M. Lawrence, A. Duggal, C. Darwin, E. Brooks, and G. Christodoulou
Prescribing patterns for psychotic and behavioural symptoms in dementia: a
national survey Psychiatr. Bull., August 1, 2002; 26(8): 288 - 290.
[Abstract]
[Full Text]
[PDF]
-
Kapur, N.,
Kopelman, M. D (2003). Advanced brain imaging procedures and human memory
disorder. Br Med
Bull 65: 61-81
[Abstract]
[Full Text]
-
Kato, T.,
Knopman, D., Liu, H. (2001). Dissociation of regional activation in mild AD
during visual encoding: A functional MRI study.
Neurology 57: 812-816
[Abstract]
[Full Text]
-
Kawas C,
Resnick S, Morrison A, et al.A prospective study of estrogen replacement
therapy and the risk of developing Alzheimer's disease: the Baltimore
longitudinal study of aging.Neurology.1997;48:1517-1521.MEDLINE
-
Kelly, C. A.
, Harvey, R. J. & Cayton, H. (1997)Drug treatments for Alzheimer's disease
Br. Med. J. 314, 693-694
-
Knable
Extract of Ginkgo biloba added to haloperidol was effective for positive
symptoms in refractory schizophrenia Evid Based Ment Health 2002;5:90-90.
FULL TEXT
-
Korczyn, A.
D. (2002). Homocysteine, Stroke, and Dementia.
Stroke 33: 2343-2344
[Full Text]
-
Krause, B. J.
, Schmidt, D. , Mottaghy, F. M. , Taylor, J. , Halsband, U. , Herzog, H. ,
Tellmann, L. & Muller-Gartner, H. W. Episodic retrieval activates the
precuneus irrespective of the imagery content of word pair associates A PET
study
(2001) Brain 122, 255-263
-
Landi, F.,
Cesari, M., Onder, G., Russo, A., Torre, S., Bernabei, R. (2003).
Non-Steroidal
Anti-Inflammatory Drug (NSAID) Use and Alzheimer Disease in
Community-Dwelling Elderly Patients.
AJGP 11: 179-185
[Abstract]
[Full Text]
-
LeBlanc ES,
Janowsky J, Chan BKS, Nelson HD. Hormone replacement therapy and cognition:
systematic review and meta-analysis.
JAMA.2001;285:1489-1499.
ABSTRACT | FULL
TEXT | PDF
-
Leveille SG, LaCroix AZ, Newton KM, Keenan NL.
Older women
and hormone replacement therapy: factors influencing late life initiation.
J Am Geriatr Soc.
1997;45:1496-1500.
MEDLINE
-
Levine, B,
Cabeza, R, McIntosh, A R, Black, S E, Grady, C L, Stuss, D T (2002).
Functional reorganisation of memory after traumatic brain injury: a study
with H2150 positron emission tomography.
J. Neurol. Neurosurg.
Psychiatry 73: 173-181
[Abstract]
[Full Text]
-
Levine, J.,
Stahl, Z., Sela, B. A., Gavendo, S., Ruderman, V., Belmaker, R. H. (2002).
Elevated Homocysteine Levels in Young Male Patients With Schizophrenia.
Am. J. Psychiatry
159: 1790-1792
[Abstract]
[Full Text]
-
Li, S.-J., Li,
Z., Wu, G., Zhang, M.-J., Franczak, M., Antuono, P. G. (2002).
Alzheimer
Disease: Evaluation of a Functional MR Imaging Index as a Marker.
Radiology 225: 253-259
[Abstract]
[Full Text]
-
Loeb C,
Gandolfo C.Diagnostic evaluation of degenerative and vascular
dementia.Stroke. 1983;14:399-401.MEDLINE
-
Lokk, J.
(2003). News and Views on Folate and Elderly Persons. J Gerontol A Biol Sci
Med Sci 58: M354-361
[Abstract]
[Full Text]
-
Lovestone, S
(2002). Can we afford to develop treatments for dementia?.
J. Neurol. Neurosurg.
Psychiatry 72: 685-685
[Full Text]
-
Luchsinger,
J. A., Tang, M.-X., Shea, S., Mayeux, R. (2003). Antioxidant Vitamin Intake
and Risk of Alzheimer Disease.
Arch Neurol 60: 203-208
[Abstract]
[Full Text]
- M.
J. de Leon, A. Convit, O. T. Wolf, C. Y. Tarshish, S. DeSanti, H. Rusinek,
W. Tsui, E. Kandil, A. J. Scherer, A. Roche, A. Imossi, E. Thorn, M.
Bobinski, C. Caraos, P. Lesbre, D. Schlyer, J. Poirier, B. Reisberg, and J.
Fowler
Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission
tomography (FDG/PET) PNAS 2001 98: 10966-10971; published
online before print as 10.1073/pnas.191044198
[Abstract]
[Full Text]
[PDF]
-
M. Lepage, O.
Ghaffar, L. Nyberg, and E. Tulving
From the Cover:
Prefrontal cortex and episodic memory retrieval mode PNAS,
January 4, 2000; 97(1): 506 - 511.
[Abstract]
[Full Text]
[PDF]
-
M.J. DeLeon,
T. Crook:The Global Deterioration Scale for assessment of primary
degenerative dementia.
Am. J. Psychiatry, 139,
1136-1139 (1982).)
-
Madeline
Murguia Rice, PhD; Amy Borenstein Graves, PhD; Susan M. McCurry, PhD; Laura
E. Gibbons, PhD; Jim D. Bowen, MD; Wayne C. McCormick, MD; Eric B. Larson,
MD, MPH Arch Intern Med. 2000;160:1641-1649
-
Maidment The
use of ginkgo biloba in the treatment of dementia Psychiatr Bull
2001;25:353-356.
ABSTRACT
|
FULL TEXT
-
Marquis, S.,
Moore, M. M., Howieson, D. B., Sexton, G., Payami, H., Kaye, J. A.,
Camicioli, R. (2002).
Independent
Predictors of Cognitive Decline in Healthy Elderly Persons. Arch Neurol 59:
601-606
[Abstract]
[Full Text]
-
Mattson, M.
P. (2003). Will caloric restriction and folate protect against AD and PD?.
Neurology 60:
690-695
[Abstract]
[Full Text]
-
Mattson, M.
P., Duan, W., Guo, Z. (2003). Meal size and frequency affect neuronal
plasticity and vulnerability to disease: cellular and molecular mechanisms.
J Neurochem 84:
417-431
[Abstract]
[Full Text]
-
Mayeux and
Sano Treatment of Alzheimer's Disease N Engl J Med 1999;341:1670-1679.
FULL TEXT
-
Mayeux, R.,
Small, S. A. (2000). Finding the Beginning or Predicting the Future?.
Arch Neurol 57: 783-784
[Full Text]
-
Mazurek, A. A.,
De Deyn, P. P., Mayeux, R., Sano, M. (2000).
Treatment of
Alzheimer's Disease. N Engl J Med 342: 821-822
[Full Text]
-
Mega, M. S.,
Small, G. W., Xu, M. L., Felix, J., Manese, M., Tran, N. P., Dailey, J. I.,
Ercoli, L. M., Bookheimer, S. Y., Toga, A. W. (2002).
Hippocampal
Atrophy in Persons With Age-Associated Memory Impairment: Volumetry Within a
Common Space.
Psychosom Med 64: 487-492
[Abstract]
[Full Text]
-
Merrill F. Elias, PhD, MPH; Alexa Beiser, PhD; Philip A. Wolf,
MD; Rhoda Au, PhD; Roberta F. White, PhD; Ralph B. D'Agostino,
PhD The Preclinical Phase of Alzheimer Disease: A 22-Year Prospective Study
of the Framingham Cohort
http://archneur.ama-assn.org/issues/v57n6/abs/noc90027.html Arch Neurol.
2000;57:808-813
-
Miller, B. L.
(2002). Past Glory and Future Promise: Maximizing and Improving
Understanding of Atrophy Patterns in the Diagnosis of Degenerative
Dementias. AJNR Am
J Neuroradiol 23: 33-34
[Full Text]
-
Miller, J. W., Selhub, J., Nadeau, M. R., Thomas, C. A., Feldman, R. G.,
Wolf, P. A. (2003).
Effect of
L-dopa on plasma homocysteine in PD patients: Relationship to B-vitamin
status. Neurology
60: 1125-1129
[Abstract]
[Full Text]
-
Montine, T.
J., Milatovic, D., Gupta, R. C., Valyi-Nagy, T., Morrow, J. D., Breyer, R.
M. (2002). Neuronal oxidative damage from activated innate immunity is EP2
receptor-dependent.
J Neurochem 83: 463-470
[Abstract]
[Full Text]
-
Morley, J. E.
(2003). Editorial: Hot Topics in Geriatrics. J Gerontol A Biol Sci Med Sci
58: M30-36
[Full Text]
-
Morris, M.
C., Evans, D. A., Bienias, J. L., Tangney, C. C., Wilson, R. S. (2002).
Vitamin E and Cognitive Decline in Older Persons. Arch Neurol 59: 1125-1132
[Abstract]
[Full Text]
-
Morrison RS,
Siu AL. Mortality from pneumonia and hip fractures in patients with advanced
dementia [letter].
JAMA. 2000;284:2447-2448.
FULL TEXT | PDF
| MEDLINE
-
Morrison RS,
Siu AL. Survival in end-stage dementia following acute illness.
JAMA. 2000;284:47-52.
ABSTRACT | FULL
TEXT | PDF
| MEDLINE
-
MRI Aids in
Diagnosis of Early Alzheimer's Disease. Journal Watch Psychiatry 2000: 5-5
[Full Text]
-
Mueggler, T., Sturchler-Pierrat, C., Baumann, D., Rausch, M., Staufenbiel,
M., Rudin, M. (2002).
Compromised
Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice. J.
Neurosci. 22: 7218-7224
[Abstract]
[Full Text]
-
Mulnard RA,
Cotman CW, Kawas C, et al.
Estrogen
replacement therapy for treatment of mild to moderate Alzheimer disease.
JAMA.
2000;283:1007-1015
ABSTRACT | FULL
TEXT
-
Nahin and
Straus Research into complementary and alternative medicine: problems and
potential BMJ 2001;322:161-164.
FULL TEXT
-
Neugroschl,
J., Davis, K. L. (2002). Biological Markers in Alzheimer Disease. AJGP 10:
660-677
[Abstract]
[Full Text]
-
New
Treatments for Alzheimer's Disease Reviewed. Journal Watch Neurology 2000:
3-3
[Full Text]
-
Nobili, F.,
Koulibaly, M., Vitali, P., Migneco, O., Mariani, G., Ebmeier, K., Pupi, A.,
Robert, P. H., Rodriguez, G., Darcourt, J. (2002). Brain Perfusion Follow-Up
in Alzheimer's Patients During Treatment with Acetylcholinesterase
Inhibitors. J Nucl
Med 43: 983-990
[Abstract]
[Full Text]
-
NSAID Use and
Risk for Alzheimer's Disease. Journal Watch (General) 2001: 2-2
[Full Text]
-
NSAID Use
and Risk for Alzheimer's Disease. Journal Watch Psychiatry 2002: 9-9
[Full Text]
-
O. L. Lopez,
S. R. Wisniewski, J. T. Becker, F. Boller, and S. T. DeKosky Psychiatric
Medication and Abnormal Behavior as Predictors of Progression in Probable
Alzheimer Disease Arch Neurol, October 1, 1999; 56(10): 1266 - 1272.
[Abstract]
[Full Text]
[PDF]
-
O'Hara et al.
Update on Alzheimer's disease: recent findings and treatments eWJM
2000;172:115-120.FULL
TEXT
- Oken
BS, Storzbach DM, Kaye JA.
The efficacy
of Ginkgo biloba on cognitive function in Alzheimer's disease.
Arch Neurol 1998;55:1409-1415
-
Paganini-Hill
A, Henderson VW.Estrogen deficiency and risk of Alzheimer's disease in
women.Am J Epidemiol.1994;140:256-261.MEDLINE
-
Paganini-Hill
A, Henderson VW.Estrogen replacement therapy and risk of Alzheimer
disease.Arch Intern Med.1996;156:2213-2217.MEDLINE
-
Pantano, P.,
Iannetti, G. D., Caramia, F., Mainero, C., Di Legge, S., Bozzao, L.,
Pozzilli, C., Lenzi, G. L. (2002).
Cortical
motor reorganization after a single clinical attack of multiple sclerosis.
Brain 125:
1607-1615
[Abstract]
[Full Text]
-
Pedreira, M. E.,
Perez-Cuesta, L. M., Maldonado, H. (2002).
Reactivation
and Reconsolidation of Long-Term Memory in the Crab Chasmagnathus: Protein
Synthesis Requirement and Mediation by NMDA-Type Glutamatergic Receptors. J.
Neurosci. 22: 8305-8311
[Abstract]
[Full Text]
-
Peskind, E. R., Wilkinson, C. W., Petrie, E. C., Schellenberg, G. D.,
Raskind, M. A. (2001).
Increased CSF
cortisol in AD is a function of APOE genotype.
Neurology 56: 1094-1098
[Abstract]
[Full Text]
-
Petitti DB,
Buckwalter JG, Crooks VC, Chiu V. Prevelence of dementia in users of hormone
replacement therapy as defined by prescription data.
J Gerontol A Biol Sci Med
Sci. 2002;57:M532-M538.
MEDLINE
-
Petrella, J.
R., Coleman, R. E., Doraiswamy, P. M. (2003). Neuroimaging and Early
Diagnosis of Alzheimer Disease: A Look to the Future.
Radiology 226: 315-336
[Abstract]
[Full Text]
-
Petrella, J. R., Lustig, C., Bucher, L. A., Jha, A. P., Doraiswamy, P. M.
(2002).
Prefrontal
Activation Patterns in Subjects at Risk for Alzheimer Disease.
AJGP 10: 112-113
[Full Text]
-
Pope, S. K.,
Shue, V. M., Beck, C. (2003). WILL A HEALTHY LIFESTYLE HELP PREVENT
ALZHEIMER'S DISEASE?.
Annu. Rev. Public Health
24: 111-132
[Abstract]
[Full Text]
-
Price, J. L.,
Ko, A. I., Wade, M. J., Tsou, S. K., McKeel, D. W., Morris, J. C. (2001).
Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer
Disease. Arch
Neurol 58: 1395-1402
[Abstract]
[Full Text]
-
Prins, N.D., den Heijer, T., Hofman, A., Koudstaal, P.J., Jolles, J.,
Clarke, R., Breteler, M.M.B. (2002).
Homocysteine
and cognitive function in the elderly: The Rotterdam Scan Study.
Neurology 59: 1375-1380
[Abstract]
[Full Text]
-
R. I.
Scahill, J. M. Schott, J. M. Stevens, M. N. Rossor, and N. C. Fox
Mapping the evolution
of regional atrophy in Alzheimer's disease: Unbiased analysis of
fluid-registered serial MRI PNAS, April 2, 2002; 99(7): 4703
- 4707.
[Abstract]
[Full Text]
[PDF]
-
Rachael I.
Scahill, Jonathan M. Schott, John M. Stevens, Martin N. Rossor, and Nick C.
Fox Mapping
the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis
of fluid-registered serial MRI PNAS 2002 99: 4703-4707.
[Abstract]
[Full Text]
[PDF]
-
Rampersaud,
G. C., Kauwell, G. P.A., Bailey, L. B. (2003). Folate: A Key to Optimizing
Health and Reducing Disease Risk in the Elderly.
J Am Coll Nutr 22: 1-8
[Abstract]
[Full Text]
-
Ravaglia, G.,
Forti, P., Maioli, F., Muscari, A., Sacchetti, L., Arnone, G., Nativio, V.,
Talerico, T., Mariani, E. (2003).
Homocysteine
and cognitive function in healthy elderly community dwellers in Italy.
Am. J. Clin. Nutr.
77: 668-673
[Abstract]
[Full Text]
-
Reisberg, B.,
Doody, R., Stoffler, A., Schmitt, F., Ferris, S., Mobius, H. J., the
Memantine Study Group, (2003). Memantine in Moderate-to-Severe Alzheimer's
Disease. N Engl J Med 348: 1333-1341
[Abstract]
[Full Text]
-
Resnick SM,
Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical
time. JAMA.
2002;288:2170-2172.
FULL TEXT | PDF
| MEDLINE
-
Resnick SM,
Maki PM. Effects of hormone replacement therapy on cognitive and brain
aging. Ann N Y Acad
Sci. 2001;949:203-214.
MEDLINE
-
Reynolds, E H
(2002). Folic acid, ageing, depression, and dementia.
BMJ 324: 1512-1515
[Full Text]
-
Rigaud AS,
Seux ML, Staessen JA, Birkenhäger WH, Forette F.Cerebral complications of
hypertension.
J Hum
Hypertens.2000;14:605-616.MEDLINE
-
Riva E,
Nobili A, Tecate F. "Judicious" use of neuroleptic drugs in the treatment of
behavioral symptoms in the course of Alzheimer Disease.
Recenti Prg Med 89(11):
598-603 (Nov. 1998)
-
Rogers, J. D.,
Sanchez-Saffon, A., Frol, A. B., Diaz-Arrastia, R. (2003).
Elevated
Plasma Homocysteine Levels in Patients Treated With Levodopa: Association
With Vascular Disease.
Arch Neurol 60: 59-64
[Abstract]
[Full Text]
-
RUCHOUX, M.-M.,
BRULIN, P., BRILLAULT, J., DEHOUCK, M.-P., CECCHELLI, R., BATAILLARD, M.
(2002). Lessons
from CADASIL. Annals NYAS Online 977: 224-231
[Abstract]
[Full Text]
-
S. S. Sisodia
and M. Gallagher A role for the beta -amyloid precursor protein in memory?
PNAS, October 13, 1998;
95(21): 12074 - 12076.
[Full Text]
[PDF
-
Santini, E.,
Muller, R. U., Quirk, G. J. (2001).
Consolidation
of Extinction Learning Involves Transfer from NMDA-Independent to
NMDA-Dependent Memory. J. Neurosci. 21: 9009-9017
[Abstract]
[Full Text]
-
Selkoe, D. J.
(2002). Alzheimer's Disease Is a Synaptic Failure.
Science 298: 789-791
[Abstract]
[Full Text]
-
Selkoe, D.
J., Schenk, D. (2003). ALZHEIMER'S DISEASE: Molecular Understanding Predicts
Amyloid-Based Therapeutics.
Annu. Rev. Pharmacol.
Toxicol. 43: 545-584
[Abstract]
[Full Text]
-
Shea, T. B., Rogers, E., Auer, J., Berent, R., Eber, B., Seshadri, S., Wolf,
P. A. (2002). Homocysteine and Dementia. N Engl J Med 346: 2007-2008
[Full Text]
-
Sheehan, B.,
Fazel, S. (2002). Elevated plasma total homocysteine increased the risk of
dementia in the elderly.
Evid Based Ment Health 5:
126-126
[Full Text]
- Shi,
Q., Savage, J. E., Hufeisen, S. J., Rauser, L., Grajkowska, E., Ernsberger,
P., Wroblewski, J. T., Nadeau, J. H., Roth, B. L. (2003).
L-Homocysteine Sulfinic Acid and Other Acidic Homocysteine Derivatives Are
Potent and Selective Metabotropic Glutamate Receptor Agonists.
J. Pharmacol. Exp. Ther.
305: 131-142
[Abstract]
[Full Text]
-
Short RA,
Bowen RL, O'Brien PC, Graff-Radford NR. Elevated gonadotropin levels in
patients with Alzheimer disease.
Mayo Clin Proc.
2001;76:906-909.
MEDLINE
-
Shumaker SA,
Reboussin BA, Espeland MA, et al.
The Women's
Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen
therapy in preventing and slowing the progression of dementia.
Control Clin Trials.
1998;19:604-621.
MEDLINE
-
Silverman, D.
H.S., Small, G. W. (2002). Prompt Identification of Alzheimer's Disease With
Brain PET Imaging of a Woman With Multiple Previous Diagnoses of Other
Neuropsychiatric Conditions.
Am. J. Psychiatry 159:
1482-1488
[Full Text]
-
Simona Capsoni, Gabriele Ugolini, Alessandro Comparini, Francesca Ruberti,
Nicoletta Berardi, and Antonino Cattaneo
Alzheimer-like
neurodegeneration in aged antinerve growth factor transgenic mice
PNAS 2000 97: 6826-6831.
[Abstract]
[Full Text]
[PDF]
-
Skoog, I.
(2000). Detection of Preclinical Alzheimer's Disease. N Engl J Med 343:
502-503
[Full Text]
-
Sloane et al.
THE PUBLIC HEALTH IMPACT OF ALZHEIMER'S DISEASE, 2000-2050: Potential
Implication of Treatment Advances Annu.
Rev. Public Health
2002;23:213-231.
ABSTRACT |
FULL TEXT
-
Smith, A D.
(2002). Homocysteine, B vitamins, and cognitive deficit in the elderly.
Am. J. Clin. Nutr.
75: 785-786
[Full Text]
-
Smith, A. D.
(2002). Imaging the progression of Alzheimer pathology through the brain.
Proc. Natl. Acad.
Sci. U. S. A. 99: 4135-4137
[Full Text]
-
Smith, C. D., Andersen, A. H., Kryscio, R. J., Schmitt, F. A., Kindy, M. S.,
Blonder, L. X., Avison, M. J. (2002).
Women at risk
for AD show increased parietal activation during a fluency task.
Neurology 58: 1197-1202
[Abstract]
[Full Text]
- Sood,
A., Mounier, N., Andre, M., Lepage, E., Hull, M., Lieb, K., Fiebich, B. L.,
Press, D., Stricker, B. H.C., Hofman, A., Breteler, M. M.B. (2002).
Nonsteroidal
Drugs and Alzheimer's Disease. N Engl J Med 346: 1171-1173
[Full Text]
-
Sperling, R
A, Bates, J F, Chua, E F, Cocchiarella, A J, Rentz, D M, Rosen, B R,
Schacter, D L, Albert, M S (2003). fMRI studies of associative encoding in
young and elderly controls and mild Alzheimer's disease.
J. Neurol. Neurosurg.
Psychiatry 74: 44-50
[Abstract]
[Full Text]
-
Stein, T. D.,
Johnson, J. A. (2002). Lack of Neurodegeneration in Transgenic Mice
Overexpressing Mutant Amyloid Precursor Protein Is Associated with Increased
Levels of Transthyretin and the Activation of Cell Survival Pathways.
J. Neurosci. 22: 7380-7388
[Abstract]
[Full Text]
-
Sudha Seshadri, MD; Gwen L. Zornberg, MD, ScD; Laura E. Derby, DSc;
Marian W. Myers, MPH; Hershel Jick, MD; David A. Drachman, MD Postmenopausal
Estrogen Replacement Therapy and the Risk of Alzheimer Disease
Arch Neurol. 2001;58:435-44
- T.
A. Rummans, E. C. Lauterbach, C. E. Coffey, D. R. Royall, J. L. Cummings, S.
Salloway, J. Duffy, and D. Kaufer Pharmacologic Efficacy in Neuropsychiatry:
A Review of Placebo-Controlled Treatment Trials J. Neuropsychiatry. Clin.
Neurosci., May 1, 1999; 11(2): 176 - 189.
[Abstract]
[Full Text]
- T.
Greenhalgh, K. Stein, R. Milne, L. Best, H Boothby, S M N Zaidi, V Seth, S
Khalaf, H Jameel, S Mahomed, A. Yassiri, P Hooper, A M Whitehead, R. W
Jones, J. B Mann, and S. A Saunders
Advertisements for
donepezil BMJ, December 13, 1997; 315(7122): 1623 - 1623.
[Full Text]
-
Tang MX,
Jacobs D, Stern Y, et al.Effect of oestrogen during menopause on risk and
age at onset of Alzheimer's disease.Lancet.1996;348:429-432.MEDLINE
Tariot PN, Erb R, Podgorski CA, et al.
Efficacy and
tolerability of carbamazepine for agitation and aggression in dementia.
Am J Psychiatry 1998;155:54-61
-
The Canadian
Study of Health and Aging: risk factors for Alzheimer's disease in
Canada.Neurology.1994;44:2073-2080.MEDLINE
-
Toole, J. F.,
Jack, C. R. (2002). Food (and vitamins) for thought.
Neurology 58: 1449-1450
[Full Text]
-
Trojanowski,
J. Q. (2002). Neuropathological Verisimilitude in Animal Models of
Alzheimer's Disease : Key to Elucidating Neurodegenerative Pathways and
Identifying New Targets for Drug Discovery.
Am J Pathol 160: 409-411
[Full Text]
-
Trojanowski,
J. Q. (2002). Neuropathological Verisimilitude in Animal Models of
Alzheimer's Disease : Key to Elucidating Neurodegenerative Pathways and
Identifying New Targets for Drug Discovery.
Am J Pathol 160: 409-411
[Full Text]
-
van der Steen
JT, Ooms ME, Adèr HJ, Ribbe MW, van der Wal G. Withholding antibiotic
treatment in pneumonia patients with dementia: a quantitative observational
study. Arch Intern
Med. 2002;162:1753-1760.
ABSTRACT | FULL
TEXT | PDF
| MEDLINE
-
van der Steen
JT, Ooms ME, van der Wal G, Ribbe MW.
Pneumonia:
the demented patient's best friend? discomfort after starting or withholding
antibiotic treatment.
J Am Geriatr Soc.
2002;50:1681-1688.
MEDLINE
-
Van Duijn CM,
Clayton D, Chandra V, et al.Familial aggregation of Alzheimer's disease and
related disorders: a collaborative re-analysis of case-control studies.Int J
Epidemiol.1991;20(suppl 2):S13-S19.MEDLINE
-
van Leeuwen, R,
Vingerling, J R, Hofman, A, de Jong, P T V M, Stricker, B H C. (2003).
Cholesterol lowering drugs and risk of age related maculopathy: prospective
cohort study with cumulative exposure measurement.
BMJ 326: 255-256
[Full Text]
-
Varner, A. E., Brenner, S., Morris, M. C., Evans, D. A., Bienias, J. L.,
Tangney, C. C., Bennett, D. A., Aggarwal, N., Wilson, R. S., Scherr, P. A.,
Engelhart, M. J., Breteler, M. M. B. (2002). Antioxidants and Risk of
Alzheimer Disease. JAMA 288: 2265-2266
[Full Text]
-
Venn, B. J.,
Grant, A. M., Thomson, C. D., Green, T. J. (2003). Selenium Supplements Do
Not Increase Plasma Total Homocysteine Concentrations in Men and Women.
J. Nutr. 133:
418-420
[Abstract]
[Full Text]
-
WAKUTANI, Y., KOWA, H., KUSUMI, M., YAMAGATA, K., WADA-ISOE, K., ADACHI, Y.,
TAKESHIMA, T., URAKAMI, K., NAKASHIMA, K. (2002).
Genetic
Analysis of Vascular Factors in Alzheimer's Disease. Annals NYAS Online 977:
232-238
[Abstract]
[Full Text]
-
Wancata,
Johannes ,Psychiat. Prax. 2000; 27: Nr. 4, S. 171-176.
Wien.
-
Wang, H., Shimizu, E., Tang, Y.-P., Cho, M., Kyin, M., Zuo, W., Robinson, D.
A., Alaimo, P. J., Zhang, C., Morimoto, H., Zhuo, M., Feng, R., Shokat, K.
M., Tsien, J. Z. (2003).
Inducible
protein knockout reveals temporal requirement of CaMKII reactivation for
memory consolidation in the brain. Proc. Natl. Acad. Sci. U. S. A. 100:
4287-4292
[Abstract]
[Full Text]
-
Wargovich et
al. Herbals, Cancer Prevention and Health J. Nutr. 2001;131:3034S-3036.
ABSTRACT |
FULL TEXT
-
Watson, W. H.,
Cai, J., Jones, D. P. (2000).
DIET AND
APOPTOSIS. Annu. Rev. Nutr. 20: 485-505
[Abstract]
[Full Text]
-
Wells, D. G., Dong, X., Quinlan, E. M., Huang, Y.-S., Bear, M. F., Richter,
J. D., Fallon, J. R. (2001).
A Role for
the Cytoplasmic Polyadenylation Element in NMDA Receptor-Regulated mRNA
Translation in Neurons. J. Neurosci. 21: 9541-9548
[Abstract]
[Full Text]
-
WHALLEY, L.
J. (2002). Brain ageing and dementia: what makes the difference?.
Br J Psychiatry 181:
369-371
[Full Text]
-
Whitmer, R.
A., Haan, M. N., Miller, J. W., Yaffe, K. (2003). Hormone Replacement
Therapy and Cognitive Performance: The Role of Homocysteine. J Gerontol A
Biol Sci Med Sci 58: M324-330
[Abstract]
[Full Text]
-
Writing Group
for the Women Health Initiative Investigators. Risks and benefits of
estrogen plus progestin in healthy postmenopausal women: principal results
from the Women's Health Initiative randomized controlled trial.
JAMA. 2002;288:321-333.
ABSTRACT | FULL
TEXT | PDF
| MEDLINE
- Xu,
J., Chen, S., Ahmed, S. H., Chen, H., Ku, G., Goldberg, M. P., Hsu, C. Y.
(2001). Amyloid-{beta} Peptides Are Cytotoxic to Oligodendrocytes. J.
Neurosci. 21: 118R-118
[Abstract]
[Full Text]
- Xu,
Y. , Jack, C. R., Jr. , O'Brien, P. C. , Kokmen, E. , Smith, G. E. , Ivnik,
R. J. , Boeve, B. F. , Tangalos, R. G. & Petersen, R. C. Usefulness of MRI
measures of entorhinal cortex versus hippocampus in
AD (2000) Neurology 54, 1760-1767
-
Yen, C.-H.,
Lau, Y.-T. (2002). Vascular Responses in Male and Female Hypertensive Rats
With Hyperhomocysteinemia.
Hypertension 40: 322-328
[Abstract]
[Full Text]
-
Zandi PP,
Carlson MC, Plassman BL, et al, for the Cache County Memory Study
Investigators. Hormone replacement therapy and incidence of Alzheimer
disease in older women: the Cache County Study.
JAMA. 2002;288:2123-2129.
ABSTRACT | FULL
TEXT | PDF
| MEDLINE
-
Zandi, P. P., Anthony, J. C., Hayden, K. M., Mehta, K., Mayer, L., Breitner,
J. C.S. (2002).
Reduced
incidence of AD with NSAID but not H2 receptor antagonists: The Cache County
Study. Neurology
59: 880-886
[Abstract]
[Full Text]
-
Zandi, P. P.,
Carlson, M. C., Plassman, B. L., Welsh-Bohmer, K. A., Mayer, L. S.,
Steffens, D. C., Breitner, J. C. S., for the Cache County Memory Study
Investigators, (2002). Hormone Replacement Therapy and Incidence of
Alzheimer Disease in Older Women: The Cache County Study.
JAMA 288: 2123-2129
[Abstract]
[Full Text]
- Maria-Jesús Sobrido, MD,
et al, Novel Tau Polymorphisms, Tau Haplotypes, and Splicing in Familial and
Sporadic Frontotemporal Dementia,
Arch Neurol. 2003;60:698-702.
-
Lawrence
S.
Honig,
et
al.,
Atherosclerosis
and
AD;
Analysis
of
data
from
the US
National
Alzheimer’s
Coordinating
Center
NEUROLOGY
2005;64:494-500'
-
R. A.
Whitmer,
Midlife
cardiovascular
risk
factors
and
risk
of
dementia
in
late
life
NEUROLOGY
2005;64:277-281
 |
Anschrift des Verfassers: (Praxisadresse) |
Feedback: |
Karl C. Mayer |
Gästebuch |
Bergheimerstraße 56a |
E-Mail |
69115 Heidelberg |
Bitte beachten Sie, diese Webseite ersetzt keine
medizinische Diagnosestellung oder Behandlung. Es wird hier
versucht einen Überblick über den derzeitigen Stand der medizinischen
Forschung auch für interessierte Laien zu geben, dies ist nicht
immer aktuell möglich. Es ist auch nicht möglich, dass ein Arzt immer auf
dem aktuellsten Stand der medizinischen Forschung in allen Bereichen
seines Faches ist. Es ist immer möglich, dass die medizinische
Forschung hier noch als wirksam und ungefährlich dargestellte
Behandlungsmaßnahmen inzwischen als gefährlich oder unwirksam erwiesen
hat. Lesen Sie bei Medikamenten immer den Beipackzettel und fragen Sie bei
Unklarheiten Ihren behandelnden Arzt. Medikamentöse Behandlungen auch mit
freiverkäuflichen Medikamenten bedürfen ärztlicher Aufsicht und Anleitung.
Dies gilt auch für alle anderen Behandlungsverfahren. Die hier angebotenen
Informationen können nicht immer für jeden verständlich sein. Um
Mitteilung wo dies nicht der Fall ist bin ich dankbar. Fragen Sie hierzu
immer Ihren behandelnden Arzt. Dieser weiß in der Regel über die hier
dargestellten Sachverhalte gut Bescheid und kann Ihren individuellen Fall
und Ihre Beschwerden besser einordnen- was für einen bestimmten Patienten
nützlich ist, kann einem anderen schaden. Selbstverständlich gibt es
zu den meisten Themen unterschiedliche Auffassungen. Soweit möglich wird
hier dargestellt woher die Informationen stammen. In den meisten Fällen
mit einem entsprechenden Link (da diese oft ohne Ankündigung geändert
werden, sind diese leider nicht immer aktuell zu halten).. Leider ist die
zitierte Literatur nicht immer kostenfrei zugänglich. Die Beschränkung auf
kostenfrei zugängliche Literatur würde manches sehr oberflächlich lassen.
In der Regel versuche ich mich in der Darstellung an deutschen oder
internationalen Leitlinien der Fachgesellschaften und Metaanalysen der
Literatur zu orientieren. Auch dies ist nicht überall möglich. Zum einen
gibt es nicht überall solche Leitlinien, zum anderen werden diese mir
nicht immer sofort bekannt. Manche Leitlinien sind lange nicht
aktualisiert worden und von neuerer Literatur überholt, bzw,
ergänzungsbedürftig. Wenn möglich sind im Text Links zu solchen
Leitlinien eingebaut. Auch Leitlinien sind nur Orientierungen, sie
schließen nicht aus, dass generell oder im Einzelfall Fehler enthalten
sind oder diese im Einzelfall nicht anwendbar sind. Ziel der Darstellung
ist hier definitiv nicht, mich als Experten für irgendeines der in der
Homepage dargestellten Krankheitsbilder auszuweisen. Ich gehe davon aus,
dass alle vergleichbaren Fachärzte für Neurologie, Psychotherapeutische
Medizin und Psychiatrie ihre Patienten sorgfältig und genau so gut wie ich
behandeln. Sollten Sie über eine Suchmaschine direkt auf diese Seite
gekommen sein, werden Sie gebeten auch die Hauptseite
aufzusuchen. Dort finden Sie einen Link zu den zuständigen Ärztekammern.
Bitte lesen sie auch den
Beipackzettel der Homepage und das Vorwort. Jeder Nutzer ist für die
Verwendung der hier gewonnenen Informationen selbst verantwortlich, es
handelt sich definitiv um keine Anleitung zur Selbstbehandlung. Es wird
keinerlei Haftung weder für die hier angebotenen Informationen noch für
die in den Links angebotenen Informationen übernommen. Sollten Sie Links
finden, die nicht (oder nicht mehr) seriös sind, teilen Sie mir dies bitte
mit, damit ich diese löschen kann. Der Autor übernimmt keinerlei Gewähr
für die Aktualität, Korrektheit, Vollständigkeit oder Qualität der
bereitgestellten Informationen. Haftungsansprüche gegen den Autor, welche
sich auf Schäden materieller oder ideeller Art beziehen, die durch die
Nutzung oder Nichtnutzung der dargebotenen Informationen bzw. durch die
Nutzung fehlerhafter und unvollständiger Informationen verursacht wurden
sind grundsätzlich ausgeschlossen, sofern seitens des Autors kein
nachweislich vorsätzliches oder grob fahrlässiges Verschulden vorliegt.
Alle Angebote sind freibleibend und unverbindlich. Der Autor behält es
sich ausdrücklich vor, Teile der Seiten oder das gesamte Angebot ohne
gesonderte Ankündigung zu verändern, zu ergänzen, zu löschen oder die
Veröffentlichung zeitweise oder endgültig einzustellen. Veränderungen
erfolgen dabei ständig in Anpassung an neue Literatur oder weil sich meine
Auffassung zu einem Thema aus anderen Gründen geändert hat. Dieser
Haftungsausschluss ist als Teil des Internetangebotes zu betrachten, von
dem aus auf diese Seite verwiesen wurde. Sofern Teile oder einzelne
Formulierungen dieses Textes der geltenden Rechtslage nicht, nicht mehr
oder nicht vollständig entsprechen sollten, bleiben die übrigen Teile des
Dokumentes in ihrem Inhalt und ihrer Gültigkeit davon unberührt.
Sollte sich jemand durch die Homepage in irgendeiner Form beleidigt,
benachteiligt oder in sonst einer Form geschädigt fühlen, bitte ich um
eine persönliche Kontaktaufnahme per E-mail
oder telefonisch bzw. per Post. Bitte nennen Sie bei Mitteilungen
Ihren vollständigen Namen und Ihre Adresse. Bei Mitteilungen von Kollegen
bitte auch Tatsache, dass sie Kollege sind, sowie die Fachbezeichnung.
Anonyme Mitteilungen sind in der Regel nicht willkommen. Karl C. Mayer
|
| |
|